Compositions and methods for identification, assessment, prevention, and treatment of AML using USP10 biomarkers and modulators
申请人:Dana-Farber Cancer Institute, Inc.
公开号:US11136409B2
公开(公告)日:2021-10-05
The present invention is based, in part, on the identification of novel USP10 biomarkers and modulators, and methods of use thereof, for identifying, assessing, preventing, and treating AML.
本发明部分基于新型 USP10 生物标记物和调节剂的鉴定及其使用方法,用于鉴定、评估、预防和治疗急性髓细胞白血病。